Associations between clozapine availability, the diagnosis of treatment-resistant schizophrenia subgroups, antipsychotic monotherapy, and concomitant psychotropics among patients with schizophrenia: a real-world nationwide study

Both the availability of clozapine prescriptions and the precise diagnosis of TRS subgroups at discharge can promote the development of an organizational culture that facilitates the treatment of patients with schizophrenia.

Authors

Institutions

Publication Details

Journal
The International Journal of Neuropsychopharmacology
Published
2025-03-28
DOI
https://doi.org/10.1093/ijnp/pyaf011
Citations
2
Primary Topic
Schizophrenia research and treatment
Type
article
Field-Weighted Citation Impact
2.94

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Associations between clozapine availability, the diagnosis of treatment-resistant schizophrenia subgroups, antipsychotic monotherapy, and concomitant psychotropics among patients with schizophrenia: a real-world nationwide study

Takashi Tsuboi, Shinichiro Ochi, Masahiro Takeshima, Fumitoshi Kodaka et al.
2 citations
The International Journal of Neuropsychopharmacology
Schizophrenia research and treatment
2.94
article

Associations between clozapine availability, the diagnosis of treatment-resistant schizophrenia subgroups, antipsychotic monotherapy, and concomitant psychotropics among patients with schizophrenia: a real-world nationwide study

Takashi Tsuboi, Shinichiro Ochi, Masahiro Takeshima, Fumitoshi Kodaka, Ken Inada, Hisashi Yamada, Hitoshi Iida, Hiroko Kashiwagi, Hiromi Tagata, Ryota Hashimoto, Hirotaka Yamagata, Naoki Hashimoto, Hikaru Hori, Hiroyuki Muraoka, Kayo Ichihashi, Toshinori Nakamura, Junya Matsumoto, Kazutaka Ohi, Jun‐ichi Iga, Tatsuya Nagasawa, Kentaro Fukumoto, Norio Yasui‐Furukori, Shuichi Ueno, Naomi Hasegawa, Shusuke Numata, Shun Igarashi
article en
2 citations

Abstract

Both the availability of clozapine prescriptions and the precise diagnosis of TRS subgroups at discharge can promote the development of an organizational culture that facilitates the treatment of patients with schizophrenia.

The International Journal of NeuropsychopharmacologyVol. 28(4)
Jikei University School of Medicine (JP), Toho University (JP), Shinshu University (JP), Kanazawa Medical University (JP), Iwate Medical University (JP), Kyorin University (JP), Akita University (JP), Hokkaido University (JP), Fukuoka University (JP), National Center of Neurology and Psychiatry (JP), University of Tokyo Hospital (JP), Gifu University (JP), Ehime University (JP), Kitasato University (JP), Dokkyo Medical University (JP), Hyogo University (JP), Tokushima University (JP)
Japanese Society of Clinical Neuropsychopharmacology, Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science
Good health and well-being
Openalex Percentile: Top 11%
Schizophrenia research and treatment
2.94
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.